Market closedNon-fractional
Procaps Group/PROC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Procaps Group
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
Ticker
PROC
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Luxembourg, Luxembourg
Employees
5,500
Website
www.procapsgroup.com
Procaps Group Metrics
BasicAdvanced
$288M
Market cap
4.97
P/E ratio
$0.51
EPS
-
Beta
-
Dividend rate
Price and volume
Market cap
$288M
Financial strength
Current ratio
1.47
Quick ratio
0.929
Long term debt to equity
573.886
Total debt to equity
753.94
Interest coverage (TTM)
1.28%
Management effectiveness
Return on assets (TTM)
6.28%
Return on equity (TTM)
373.70%
Valuation
Price to earnings (TTM)
4.972
Price to revenue (TTM)
0.626
Price to book
6.53
Price to tangible book (TTM)
-33.33
Price to free cash flow (TTM)
7.61
Growth
Revenue change (TTM)
-4.80%
Earnings per share change (TTM)
-12.90%
What the Analysts think about Procaps Group
Analyst Ratings
Majority rating from 2 analysts.
Procaps Group Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$118M
7.64%
Net income
$8.1M
-69.89%
Profit margin
6.84%
-72.02%
Procaps Group Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
$0.10
$0.07
$0.27
$0.08
-
Expected
$0.01
-$0.04
-
$0.05
$0.09
Surprise
900.00%
-275.00%
-
60.00%
-
Procaps Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Procaps Group stock?
Procaps Group (PROC) has a market cap of $288M as of July 27, 2024.
What is the P/E ratio for Procaps Group stock?
The price to earnings (P/E) ratio for Procaps Group (PROC) stock is 4.97 as of July 27, 2024.
Does Procaps Group stock pay dividends?
No, Procaps Group (PROC) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Procaps Group dividend payment date?
Procaps Group (PROC) stock does not pay dividends to its shareholders.
What is the beta indicator for Procaps Group?
Procaps Group (PROC) does not currently have a Beta indicator.
Buy or sell Procaps Group stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.